Graham Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-9,018
| Closed | -$224K | – | 1500 |
|
|
2025
Q1 | $224K | Sell |
9,018
-3,250
| -26% | -$80.8K | ﹤0.01% | 1067 |
|
|
2024
Q4 | $231K | Sell |
12,268
-61,645
| -83% | -$1.16M | ﹤0.01% | 1003 |
|
|
2024
Q3 | $1.11M | Buy |
+73,913
| New | +$1.11M | 0.02% | 395 |
|
|
2024
Q1 | – | Sell |
-6,486
| Closed | -$219K | – | 1223 |
|
|
2023
Q4 | $219K | Sell |
6,486
-1,555
| -19% | -$52.5K | ﹤0.01% | 792 |
|
|
2023
Q3 | $247K | Buy |
+8,041
| New | +$247K | 0.01% | 774 |
|
|
2023
Q2 | – | Sell |
-14,918
| Closed | -$609K | – | 1216 |
|
|
2023
Q1 | $609K | Sell |
14,918
-12,741
| -46% | -$520K | 0.02% | 671 |
|
|
2022
Q4 | $1.07M | Buy |
+27,659
| New | +$1.07M | 0.03% | 496 |
|
|
2022
Q3 | – | Sell |
-5,446
| Closed | -$317K | – | 1250 |
|
|
2022
Q2 | $317K | Buy |
+5,446
| New | +$317K | 0.01% | 803 |
|